NCT02005198View on ClinicalTrials.gov

Assessing the Minimal Important Difference (MID) of the Treatment Related Impact Measure-Adult Growth Hormone Deficiency (TRIM-AGHD)

CompletedOBSERVATIONAL
Enrollment

98

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Growth Hormone DisorderAdult Growth Hormone Deficiency
Interventions
OTHER

No treatment given

Subject will only fill out a questionnaire when entering the non-interventional study

Trial Locations (1)

08540

Novo Nordisk Investigational Site, Princeton

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY